🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed research program will investigate the changes in brain chemist...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2018-02-26
Trial ID
NCT03471182
Examination of the fetal brain at autopsy is technically challenging becaus...
Status
Withdrawn
Location
Mount Sinai Hospital
Start Date
2007-08
Trial ID
NCT00686530
Treatments Being Tested
Bronchiolitis Obliterans Syndrome (BOS) is a major complication of Hematopo...
Status
Completed
Location
CHU Bordeaux
Start Date
2020-02-06
Trial ID
NCT04080232
Treatments Being Tested
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453
This phase II trial tests how well pembrolizumab in addition to chemotherap...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT07275216
This phase I/II trial studies the side effects and best dose of nivolumab w...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2019-06-17
Trial ID
NCT03604978
This phase I trial tests the safety, side effects, and best dose of combina...
Status
Recruiting
Location
Los Angeles General Medical Center
Start Date
2024-02-06
Trial ID
NCT05711615
Heart failure with preserved ejection fraction (HFpEF) causes symptoms of b...
Status
Recruiting
Location
Sheffield Teaching Hospitals NHS Foundation Trust
Start Date
2025-08-05
Trial ID
NCT06905405
Treatments Being Tested
This pilot phase I trial studies how well positron emission tomography (PET...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-15
Trial ID
NCT02390635
This phase II trial compares the effect of sacituzumab govitecan and bevaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07504588